Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Co-prenozide (Oxprenolol hydrochloride/cyclopenthiazide)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-prenozide 160mg/0.25mg modified-release tablets
0204000Y0AAAAAA
|
Co-prenozide | Co-prenozide (Oxprenolol hydrochloride/cyclopenthiazide) | Cardiovascular System | No data available |
|
Trasidrex modified-release tablets
0204000Y0BBAAAA
|
Trasidrex | Co-prenozide (Oxprenolol hydrochloride/cyclopenthiazide) | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.